LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced a delay in the dispatch of its circular related to the Entrusted Products Related Framework Agreement, extending the date to on or before November 20, 2024. This postponement allows more time to prepare and finalize vital information for shareholders. Investors in LEPU ScienTech should stay informed about these developments that may impact their investment decisions.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.